Cart
sales@molnova.com
Melilotoside
CAS No. 618-67-7
Melilotoside( ——— )
Catalog No. M38416 CAS No. 618-67-7
trans-Melilotoside (compound 3) is a natural product that could be isolated form Mikania laevigata.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMelilotoside
-
NoteResearch use only, not for human use.
-
Brief Descriptiontrans-Melilotoside (compound 3) is a natural product that could be isolated form Mikania laevigata.
-
Descriptiontrans-Melilotoside (compound 3) is a natural product that could be isolated form Mikania laevigata.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number618-67-7
-
Formula Weight326.301
-
Molecular FormulaC15H18O8
-
Purity>98% (HPLC)
-
SolubilityDMSO : 100 mg/mL (306.47 mM; ultraphonic (<60°C))
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Assunta E, et, al. Potential allelopathic interference of Melilotus neapolitana metabolites on three coexisting species of Mediterranean herbaceous plant community. Journal of Plant Interactions. 2008;3(3): 199-210.
molnova catalog
related products
-
ASC-JM-17
ASC-JM-17 is an activator of both Nrf1 and Nrf2 proteins. ASC-JM17 acts on Nrf1, Nrf2 and Hsf1 to increase the expression of proteasome subunits, antioxidant enzymes and molecular chaperones.
-
Chamigrenal
β-Chamigrenal has anti-inflammatory activity, it has inhibitory effects on lipopolysaccharide-induced nitric oxide and prostaglandin E2 production in RAW 264.7 macrophages.
-
Dihydrotachysterol
Dihydrotachysterol (HSDB 3314) is a vitamin D analog.Dihydrotachysterol has been used to study hypocalcemic hypoparathyroidism after surgical removal of the parathyroid glands and growth impairment in children with chronic renal insufficiency.
